BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 14335145)

  • 1. A STUDY OF COMPARATIVE CHEMICAL AND BIOLOGICAL ACTIVITIES OF ALKYLATING AGENTS.
    BARDOS TJ; DATTA-GUPTA N; HEBBORN P; TRIGGLE DJ
    J Med Chem; 1965 Mar; 8():167-74. PubMed ID: 14335145
    [No Abstract]   [Full Text] [Related]  

  • 2. COMPARATIVE PHARMACOLOGY OF ALKYLATING AGENTS. 3. TOXICITY DATA ON MONKEYS AND DOGS.
    SCHMIDT LH; FRADKIN R; SULLIVAN R; FLOWERS A
    Cancer Chemother Rep; 1965 Jan; 18():SUPPL 2:1017+. PubMed ID: 14278900
    [No Abstract]   [Full Text] [Related]  

  • 3. EXPERIMENTAL CHEMOTHERAPY STUDIES. IV. THE PROTECTIVE ACTION OF MERCAPTOALKYLAMINES AGAINST ALKYLATING AGENTS.
    RUTMAN RJ; LEWIS FS; PRICE CC
    Cancer Res; 1964 May; 24():626-33. PubMed ID: 14188465
    [No Abstract]   [Full Text] [Related]  

  • 4. COMPARATIVE PHARMACOLOGY OF ALKYLATING AGENTS. II. THERAPEUTIC ACTIVITIES OF ALKYLATING AGENTS AND REFERENCE COMPOUNDS AGAINST VARIOUS TUMOR SYSTEMS.
    SCHMIDT LH; FRADKIN R; SULLIVAN R; FLOWERS A
    Cancer Chemother Rep; 1965 Jan; 18():SUPPL 2:403+. PubMed ID: 14278902
    [No Abstract]   [Full Text] [Related]  

  • 5. EXPERIMENTAL CHEMOTHERAPY STUDIES. V. THE COLLATERAL SENSITIVITY TO ALKYLATING AGENTS OF SEVERAL ANTIMETABOLITE-RESISTANT ASCITES TUMORS IN MICE.
    RUTMAN RJ
    Cancer Res; 1964 May; 24():634-8. PubMed ID: 14188466
    [No Abstract]   [Full Text] [Related]  

  • 6. POTENTIAL ANTICANCER AGENTS. LXXX. ALKYLATING AGENTS RELATED TO PHENYLALANINE MUSTARD. VI. ENANTIOMERIC META-PHENYLALANINE MUSTARDS.
    GRAM HF; BERRIDGE BJ; ACTON EM; GOODMAN L
    J Med Chem; 1963 Jan; 6():85-7. PubMed ID: 14174040
    [No Abstract]   [Full Text] [Related]  

  • 7. THE TREATMENT OF CARCINOMA IN DOGS' BLADDERS WITH CYTOTOXIC DRUGS.
    BOYLAND E; KINDER CH; WILLIAMS K
    Invest Urol; 1965 Mar; 2():446-52. PubMed ID: 14261785
    [No Abstract]   [Full Text] [Related]  

  • 8. COMPARATIVE PHARMACOLOGY OF ALKYLATING AGENTS. I.
    SCHMIDT LH; FRADKIN R; SULLIVAN R; FLOWERS A
    Cancer Chemother Rep; 1965 Jan; 18():SUPPL 2:1-401. PubMed ID: 14278901
    [No Abstract]   [Full Text] [Related]  

  • 9. ALKYLATING AGENTS DERIVED FROM INDOLES. IV. SYNTHESIS OF THE 5-NITROGEN MUSTARD OF INDOLE-3-CARBOXYLIC ACID.
    DEGRAW J; GOODMAN L
    J Med Chem; 1964 Mar; 7():213-5. PubMed ID: 14187378
    [No Abstract]   [Full Text] [Related]  

  • 10. POTENTIAL ANTICANCER AGENTS. II. THE SYNTHESIS OF SOME NITROGEN MUSTARD CONTAINING SULFONES AND THIOSULFINATES.
    HIRSCH AF; PIANTADOSI C; IRVIN JL
    J Med Chem; 1965 Jan; 8():10-4. PubMed ID: 14287239
    [No Abstract]   [Full Text] [Related]  

  • 11. SYNTHESIS OF POTENTIAL DUAL ANTAGONISTS. 3. RING-SUBSTITUTED ETHYL (BIS(1-AZIRIDINYL)PHOSPHINYL)CARBAMATES.
    BARDOS TJ; BARUA AK; CHMIELEWICZ ZF; CREVAR GE; DAILEY JP; DIVALD S; PAPANASTASSIOU ZB
    J Pharm Sci; 1965 Feb; 54():187-90. PubMed ID: 14293801
    [No Abstract]   [Full Text] [Related]  

  • 12. THE EFFECTS OF ALKYLATING AGENTS ON FERTILITY.
    JACKSON H
    Br Med Bull; 1964 May; 20():107-14. PubMed ID: 14171898
    [No Abstract]   [Full Text] [Related]  

  • 13. REDUCTION OF THE TOXICITY OF "RADIOMIMETIC" ALKYLATING AGENTS IN RATS BY THIOL PRETREATMENT. II. MECHANISM OF PROTECTION.
    CALCUTT G; CONNORS TA; ELSON LA; ROSS WC
    Biochem Pharmacol; 1963 Aug; 12():833-7. PubMed ID: 14071540
    [No Abstract]   [Full Text] [Related]  

  • 14. PHARMACOLOGICAL STUDIES OF SEVERAL NEW ANTITUMOUR AGENTS.
    HSU B; KAO YS; TSAI JS; CHOU CH; LIU MC; SHEN ML; OWEN TY; JEN YF; PAN PC; LI SW
    Sci Sin; 1964 May; 13():789-800. PubMed ID: 14170539
    [No Abstract]   [Full Text] [Related]  

  • 15. REDUCTION OF THE TOXICITY OF "RADIOMIMETIC" ALKYLATING AGENTS IN RATS BY THIOL PRE-TREATMENT. IV. PROTECTION AGAINST BONE MARROW DAMAGE.
    CONNORS TA; DOUBLE JA; ELSON LA; JENEY A
    Biochem Pharmacol; 1965 Apr; 14():569-77. PubMed ID: 14330623
    [No Abstract]   [Full Text] [Related]  

  • 16. FURTHER INVESTIGATIONS OF HETEROCYCLIC ALKYLATING AGENTS.
    PRESTON RK; PECK RM; BREUNINGER ER; MILLER AJ; CREECH HJ
    J Med Chem; 1964 Jul; 7():471-80. PubMed ID: 14221129
    [No Abstract]   [Full Text] [Related]  

  • 17. EXPERIMENTAL STUDY OF SOME BICYCLIC BIS-(BETA-CHLORETHYL)AMINES.
    KRAVCHENKO AI
    Fed Proc Transl Suppl; 1964; 23():893-5. PubMed ID: 14196960
    [No Abstract]   [Full Text] [Related]  

  • 18. REDUCTION OF THE TOXICITY OF 'RADIOMIMETIC' ALKYLATING AGENTS IN RATS BY THIOL PRETREATMENT. 3. THE MECHANISM OF THE PROTECTIVE ACTION OF THIOSULPHATE.
    CONNORS TA; JENEY A; JONES M
    Biochem Pharmacol; 1964 Dec; 13():1545-50. PubMed ID: 14248383
    [No Abstract]   [Full Text] [Related]  

  • 19. POTENTIAL ANTICANCER AGENTS. IV. HETEROCYCLIC PHOSPHORAMIDE NITROGEN MUSTARDS.
    ZIMMER H; SILL AD
    Arzneimittelforschung; 1964 Feb; 14():150-1. PubMed ID: 14229652
    [No Abstract]   [Full Text] [Related]  

  • 20. [STUDIES ON ANTITUMOUR DRUGS. 18. EXPERIMENTAL THERAPY AND TOXICITY OF 5-(BIS-(2-CHLOROETHYL)-AMINO)-INDOLE-2-CARBOXYLIC ACID (AT-346)].
    CHOU CH; WANG TY; LIANG HC; HSU B
    Yao Xue Xue Bao; 1964 Nov; 11():735-43. PubMed ID: 14235241
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.